Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences to Release Second Quarter 2022 Financial Results and Host Conference Call on Monday, August 8
05:00pm, Monday, 25'th Jul 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will release its financial results for the second quarter and six months ended June 30, 2022, on Monday, Aug. 8, 2022.
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
08:13am, Wednesday, 11'th May 2022
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF.
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
10:15pm, Monday, 09'th May 2022 Zacks Investment Research
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of -19.40% and 6.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
Castle Biosciences, Inc. (CSTL) CEO Derek Maetzold on Q1 2022 Results - Earnings Call Transcript
09:54pm, Monday, 09'th May 2022
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q1 2022 Results Conference Call May 9, 2022 4:30 PM ET Company Participants Camilla Zuckero - Executive Director of Investor Relations and Corporate Communicati
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Monday, 09'th May 2022
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of -19.40% and 6.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates
01:15pm, Thursday, 05'th May 2022 Zacks Investment Research
C4 Therapeutics, Inc. (CCCC) delivered earnings and revenue surprises of -6.56% and 0.16%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Castle Biosciences to Release First Quarter 2022 Financial Results and Host Conference Call on Monday, May 9
05:00pm, Monday, 25'th Apr 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences will release its financial results for the first quarter ended March 31, 2022, after the close of market on Monday, May 9, 2022.
Castle Biosciences to Present Data at the 18th European Association of Dermato Oncology (EADO) Congress
05:00pm, Wednesday, 20'th Apr 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle will present data on its skin cancer gene expression profile tests at the 18th European Association of Dermato Oncology (EADO) Congress.
Castle Biosciences to Present at the 21st Annual Needham Virtual Healthcare Conference
05:00pm, Tuesday, 05'th Apr 2022
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences will present a company overview at the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, at 3:00 p.m. ET.
Castle Biosciences posts data to highlight outperformance of DecisionDx-Melanoma test
01:06pm, Friday, 11'th Mar 2022 Seeking Alpha
On Friday, the commercial-stage diagnostics company, Castle Biosciences (CSTL), announced new data to claim that its gene expression profile test, DecisionDx-Melanoma, performed better…
Is it Still Safe to Invest in Castle Biosciences (CSTL)?
01:41pm, Monday, 07'th Mar 2022 Insider Monkey
Wasatch Global Investors, an investment management firm, published its "Wasatch Micro Cap Fund" fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Castle Biosciences, Inc.''s (CSTL) CEO Derek Maetzold On Q4 2021 Results - Earnings Call Transcript
01:15am, Tuesday, 01'st Mar 2022 Seeking Alpha
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
11:15pm, Monday, 28'th Feb 2022 Zacks Investment Research
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 41.86% and 6.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the st
Castle Biosciences GAAP EPS of -$0.25 beats by $0.23, revenue of $25M beats by $0.85M
09:15pm, Monday, 28'th Feb 2022 Seeking Alpha
Castle Biosciences press release (CSTL): Q4 GAAP EPS of -$0.25 beats by $0.23.Revenue of $25M (+44.5% Y/Y) beats by $0.85M.
Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results
09:05pm, Monday, 28'th Feb 2022 Business Wire
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #BarrettsEsophagus--Castle today announced its financial results for the fourth quarter and twelve months ended Dec. 31, 2021.
